Abstract:<bold>Background</bold>: The ratio of fibrinogen to gamma-glutamine transferase (FGR) was used to predict long-term prognosis in patients with coronary heart disease (CHD). <bold>Methods</bold>: A total of 5638 patients with CHD who were hospitalized from January 2008 to December 2016 were retrospectively enrolled in the study. The mean follow-up time was 35.9 +/-+/- 22.5 months. The follow-up endpoints were major cardiac and cerebrovascular adverse events (MACCE). The optimal FGR cut-off value was determined and divided into high- and low-FGR groups according to the receiver operating characteristic (ROC) curve. Statistical methods were used to compare the differences between the two groups and their prognoses to determine whether FGR can predict prognosis in patients with CHD. The traditional predictors were incorporated into the logistic regression model to observe the correlation between these indicators and all-cause mortality (ACM) events. We compared the prediction performance of FGR and traditional predictors on the occurrence of ACM events by ROC curves. <bold>Results</bold>: The optimal cut-off value was determined via a ROC analysis (FGR = 1.22, p = 0.002), and subjects were classified into high and low FGR groups. The follow-up found that the incidence of MACCE in the high FGR group was higher than that in the low FGR group. The COX multivariate regression model showed that high FGR was independently correlated with the occurrence of MACCE. In addition, the Kaplan-Meier survival curve showed that the risk of events was significantly increased in the group with high FGR. With increases in the FGR ratio, the risk of MACCE was increased. The ROC curve revealed that the risk of ACM was statistically different between the FGR and the traditional risk factor model (p = 0.002), (Fibrinogen (p = 0.008), gamma-glutamine transferase (GGT) (p = 0.004), and N-terminal pro brain natriuretic peptide (NT-ProBNP) (p = 0.024)). The comparison between other different models were not statistically significant (p >> 0.05). The area under the FGR model curve was larger than that of the traditional risk factors, fibrinogen, GGT and NT-ProBNP models. <bold>Conclusions</bold>: High FGR can increase the risk of MACCE in patients with CHD; additionally, it can be used as a new biomarker for long-term prognosis in CHD patients.

Fibrinogen to HDL-Cholesterol ratio as a predictor of mortality risk in patients with acute myocardial infarction

Predictive Value of Plasma Fibrinogen Levels in Patients Admitted for Acute Coronary Syndrome

The predictive value of serum fibrinogen and platelet distribution width for long-term cardiac death in acute myocardial infarction patients

Identification Of Potential Biomarkers And Immune Cell Infiltration In Acute Myocardial Infarction (Ami) Using Bioinformatics Strategy

The association between fibrinogen-to-albumin ratio and adverse prognosis in patients with myocardial infarction with non-obstructive coronary arteries

U-Shaped Relationship Between Fibrinogen Level and 10-Year Mortality in Patients with Acute Coronary Syndrome: Prospective Cohort Study

Lipidomic analyses reveal potential biomarkers for predicting death and heart failure after acute myocardial infarction

The Impact of Preoperative Fibrinogen-Albumin Ratio on Mortality in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Fibrinogen is Related to Long-Term Mortality in Chinese Patients with Acute Coronary Syndrome but Failed to Enhance the Prognostic Value of the GRACE Score.

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

Study on the Correlation Between Plasma Fibrinogen Acute Myocardial Infarctionand the Its Risk Factors

The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction

Association of high fibrinogen to albumin ratio with long-term mortality in patients with spontaneous intracerebral hemorrhage

Combination of C-reactive protein and fibrinogen-to-albumin ratio as a novel predictor of all-cause mortality in heart failure patients

Serum IGFBP5 As a Predictor of Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction

Predictive Value of the Fibrinogen to Gamma-Glutamine Transferase Ratio in the Long-Term Outcome in Patients with Coronary Heart Disease: A Retrospective Cohort Study

Value of fibrinogen in predicting long-term cardiovascular events in patients with acute coronary syndrome after intervention treatment

Hyperfibrinogenemia is Significantly Associated with an Increased Risk of In-hospital Mortality in Acute Ischemic Stroke Patients.

Relation Between Admission Plasma Fibrinogen Levels and Mortality in Chinese Patients with Coronary Artery Disease

Free fatty acids: independent predictors of long-term adverse cardiovascular outcomes in heart failure patients

D-Dimer to Fibrinogen Ratio As a Novel Prognostic Marker in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.